J. McKenzie
Statistics and Probability · British medical journal · 2018–2022
A researcher in the Science corpus: 10 papers; trusts 4 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Statistics and Probability — 209 citations into it; #11,907 of 12,932 by trust here, #1,100 by citations
- General Health Professions — 110 citations into it
- Economics and Econometrics — 70 citations into it
- History and Philosophy of Science — 19 citations into it
Whom J. McKenzie trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- David Moher
- Matthew J. Page
- Douglas G. Altman
- A. Liberati
- Larissa Shamseer
- J. Tetzlaff
- S. Brennan
- K. F. Schulz
- Mike Clarke
- L. Stewart
Who trusts J. McKenzie overall
Papers from J. McKenzie's perspective
Ordered by how strongly the researchers J. McKenzie trusts endorse each paper. Same corpus, a different order for every researcher.
- Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement and extensions: a scoping review (Systematic Reviews)
- PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation (Annals of Internal Medicine)
- Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies (British medical journal)
- PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews (British medical journal)
- PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews (Journal of the Medical Library Association)
- Meta-analysis and the science of research synthesis (Nature)
- Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ (BMC Medical Research Methodology)
- Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline (British medical journal)
- Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement. (Journal of Clinical Epidemiology)
- Evaluation of the Endorsement of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement on the Quality of Published Systematic Review and Meta-Analyses (PLoS ONE)
Their papers
- PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews (2020) — 10,812 citations
- Synthesizing and presenting findings using other methods (2019) — 559 citations
- Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline (2020) — 3,632 citations
- Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement. (2020) — 2,634 citations
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2020) — 94,440 citations
- The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. (2021) — 3,176 citations
- Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement (2022) — 649 citations
- The PRISMA 2020 statement: An updated guideline for reporting systematic reviews (2021) — 25,061 citations
- Defining the criteria for including studies and how they will be grouped for the synthesis (2019) — 368 citations
- Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration (2018) — 381 citations